Bolt Biotherapeutics Stock (NASDAQ: BOLT) stock price, news, charts, stock research, profile.
You can purchase shares of Bolt Biotherapeutics (NASDAQ:BOLT) through any online brokerage.
Other companies in Bolt Biotherapeutics’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), Nanoviricides (AMEX:NNVC), Geovax Labs (NASDAQ:GOVX), Palatin Techs (AMEX:PTN) and GlycoMimetics (NASDAQ:GLYC).
Bolt Biotherapeutics has a consensus price target of $2.38.
The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $0.56 last updated November 21, 2024 at 10:37 AM EST.
A quarterly cash dividend of 0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on October 2, 2014 to stockholders of record on September 1, 2014.
Bolt Biotherapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Bolt Biotherapeutics.
Bolt Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.